In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: studies of the mode of action in Staphylococcus aureus.

Source:http://linkedlifedata.com/resource/pubmed/id/18443108

Download in:

View as

General Info

PMID
18443108